Editorial
Copyright ©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 101994
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101994
Figure 1
Figure 1 A novel mechanism targeting β-arrestin-2 for the management of diabetic nephropathy. β-arrestin-2 may trigger endoplasmic reticulum stress via activating transcription factor 6 signaling pathway, thereby promoting glomerular endothelial cell apoptosis and exacerbating diabetic nephropathy progression. ER: Endoplasmic reticulum; ATF6: Activating transcription factor 6. The schematic model is plotted with BioRender (https://www.biorender.com).